Oxidation-reduction states of pyridine nucleotide and cytochrome P-450 during mixed-function oxidation in perfused rat liver. 1981

T Iyanagi, and T Suzaki, and S Kobayashi

The spectral changes of cytochrome P-450 associated with mixed-function oxidation of hexobarbital and aminopyrine were investigated in perfused rat liver, using reflectance spectrophotometry. Simultaneously, the oxidation-reduction state of pyridine nucleotide(s) and oxygen uptake were measured from the same liver. Difference spectra were observed after infusion of hexobarbital or aminopyrine. Spectra obtained from livers of fasted, sodium phenobarbital-treated rats were similar to those of cytochrome P-450 . substrate complex (type I); the spectrum from fed, sodium phenobarbital-treated rats was a mixture of substrate . cytochrome P-450 complex and reduced (an oxygenated) cytochrome P-450. In fed, sodium phenobarbital-treated rats, the steady state level of reduced (an oxygenated) cytochrome P-450 was dependent on the concentration and the kind of substrates added, and the level correlated well with mixed-function oxidase activity. In the absence of exogenous substrates, the degree of the formation of reduced (an oxygenated) cytochrome P-450 was small. These results indicate that mixed-function oxidase activity in the intact cell is regulated by substrate-binding to cytochrome P-450. In fasted, sodium phenobarbital-treated rats, a substantial oxidation of pyridine nucleotide was observed in the presence of hexobarbital. The increase of oxygen uptake was a 2- to 2.5-fold smaller rate than in livers from fed, sodium phenobarbital-treated rats. Infusion of sorbitol (2 mM), a glycogenic substrate in fasted rats, stimulated oxygen uptake about 3-fold. Furthermore, reduced (an oxygenated) cytochrome P-450 increased in the presence of sorbitol. These results indicate that the rate of NADPH supply is rate-limiting for mixed-function oxidation in livers of fasted, sodium phenobarbital-treated rats. Finally, the difference spectrum of cytochrome P-450, the surface fluorescence of pyridine nucleotide, and the oxygen uptake were compared using livers from untreated, alloxan-treated and sodium phenobarbital-treated rats.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D009243 NAD A coenzyme composed of ribosylnicotinamide 5'-diphosphate coupled to adenosine 5'-phosphate by pyrophosphate linkage. It is found widely in nature and is involved in numerous enzymatic reactions in which it serves as an electron carrier by being alternately oxidized (NAD+) and reduced (NADH). (Dorland, 27th ed) Coenzyme I,DPN,Diphosphopyridine Nucleotide,Nadide,Nicotinamide-Adenine Dinucleotide,Dihydronicotinamide Adenine Dinucleotide,NADH,Adenine Dinucleotide, Dihydronicotinamide,Dinucleotide, Dihydronicotinamide Adenine,Dinucleotide, Nicotinamide-Adenine,Nicotinamide Adenine Dinucleotide,Nucleotide, Diphosphopyridine
D009249 NADP Nicotinamide adenine dinucleotide phosphate. A coenzyme composed of ribosylnicotinamide 5'-phosphate (NMN) coupled by pyrophosphate linkage to the 5'-phosphate adenosine 2',5'-bisphosphate. It serves as an electron carrier in a number of reactions, being alternately oxidized (NADP+) and reduced (NADPH). (Dorland, 27th ed) Coenzyme II,Nicotinamide-Adenine Dinucleotide Phosphate,Triphosphopyridine Nucleotide,NADPH,Dinucleotide Phosphate, Nicotinamide-Adenine,Nicotinamide Adenine Dinucleotide Phosphate,Nucleotide, Triphosphopyridine,Phosphate, Nicotinamide-Adenine Dinucleotide
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D010088 Oxidoreductases The class of all enzymes catalyzing oxidoreduction reactions. The substrate that is oxidized is regarded as a hydrogen donor. The systematic name is based on donor:acceptor oxidoreductase. The recommended name will be dehydrogenase, wherever this is possible; as an alternative, reductase can be used. Oxidase is only used in cases where O2 is the acceptor. (Enzyme Nomenclature, 1992, p9) Dehydrogenases,Oxidases,Oxidoreductase,Reductases,Dehydrogenase,Oxidase,Reductase
D010101 Oxygen Consumption The rate at which oxygen is used by a tissue; microliters of oxygen STPD used per milligram of tissue per hour; the rate at which oxygen enters the blood from alveolar gas, equal in the steady state to the consumption of oxygen by tissue metabolism throughout the body. (Stedman, 25th ed, p346) Consumption, Oxygen,Consumptions, Oxygen,Oxygen Consumptions
D010477 Perfusion Treatment process involving the injection of fluid into an organ or tissue. Perfusions
D010634 Phenobarbital A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations. Phenemal,Phenobarbitone,Phenylbarbital,Gardenal,Hysteps,Luminal,Phenobarbital Sodium,Phenobarbital, Monosodium Salt,Phenylethylbarbituric Acid,Acid, Phenylethylbarbituric,Monosodium Salt Phenobarbital,Sodium, Phenobarbital

Related Publications

T Iyanagi, and T Suzaki, and S Kobayashi
April 1978, The Journal of biological chemistry,
T Iyanagi, and T Suzaki, and S Kobayashi
August 1982, The Journal of biological chemistry,
T Iyanagi, and T Suzaki, and S Kobayashi
August 1971, Biochemical and biophysical research communications,
T Iyanagi, and T Suzaki, and S Kobayashi
April 1985, Digestive diseases and sciences,
T Iyanagi, and T Suzaki, and S Kobayashi
February 1974, Masui. The Japanese journal of anesthesiology,
T Iyanagi, and T Suzaki, and S Kobayashi
February 1980, Biochemical pharmacology,
T Iyanagi, and T Suzaki, and S Kobayashi
September 1988, The Journal of pharmacology and experimental therapeutics,
Copied contents to your clipboard!